Related Experiment Videos
The role of dyslipidemia and statins in venous thromboembolism
Joel G Ray1, Frits R Rosendaal
1Department of Medicine, University of Toronto, Toronto, and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. rayjg@mcmaster
Abstract:
Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins